Recent Quotes

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development, and under review for approval by the Food and Drug Administration.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-09
REV		(EXPECTED)2021-08-09

Q1 2021		Est.		Actual		Surprise
EPS		0.650		0.240		-0.4100
REV		45.410M		41.249M		-4.161M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
EGRX	Eagle Pharmaceuticals	42.89	-0.55	-1.27%		562.7M

Eagle Pharmaceuticals Frequently Asked Questions

How do I buy Eagle Pharmaceuticals (EGRX) stock?

You can purchase shares of Eagle Pharmaceuticals (NASDAQ: EGRX) through any online brokerage.

View our list of the best stock brokerages.

Who are Eagle Pharmaceuticals's (EGRX) competitors?

Other companies in Eagle Pharmaceuticals’s space includes: Orchard Therapeutics (NASDAQ:ORTX), Altimmune (NASDAQ:ALT), Atossa Therapeutics (NASDAQ:ATOS), Adaptimmune Therapeutics (NASDAQ:ADAP) and VistaGen Therapeutics (NASDAQ:VTGN).

What is the target price for Eagle Pharmaceuticals (EGRX) stock?

The latest price target for Eagle Pharmaceuticals (NASDAQ: EGRX) was reported by Cantor Fitzgerald on March 2, 2020. The analyst firm set a price target for 46.00 expecting EGRX to rise to within 12 months (a possible 7.25% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Eagle Pharmaceuticals (EGRX)?

The stock price for Eagle Pharmaceuticals (NASDAQ: EGRX) is $42.89 last updated Fri Jun 18 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does Eagle Pharmaceuticals (EGRX) pay a dividend?

There are no upcoming dividends for Eagle Pharmaceuticals.

When is Eagle Pharmaceuticals (NASDAQ:EGRX) reporting earnings?

Eagle Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 9, 2021.

Is Eagle Pharmaceuticals (EGRX) going to split?

There is no upcoming split for Eagle Pharmaceuticals.

What sector and industry does Eagle Pharmaceuticals (EGRX) operate in?

Eagle Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.